
Extendicare Inc's stock is facing a downturn, reflecting investor concerns about its recent performance.
Extendicare Inc (EXE.TO) is experiencing a notable decline in its stock price, sliding by 2.72% in today's trading session. This drop raises questions about the company's current standing in the market and investor sentiment.
Advertisement
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
Advertisement
Market cap
$3.11B
P/E
25.0x
Div. yield
1.59%
Div. / share
$0.51
52W high
$39.09
52W low
$12.39
1W change
+0.92%
Beta
1.16
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 21.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$39.72
+21.3% Upside
Current Price
C$32.74
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
30.9%
Annualized
90-Day Vol
35.3%
Annualized
Trend (90d)
-19.6%
Annualized drift
90d Mean
C$30.53
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$31.99 | C$28.76 – C$35.58 |
| 60 trading days | C$31.25 | C$26.88 – C$36.33 |
| 90 trading days | C$30.53 | C$25.39 – C$36.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor Extendicare's performance and consider the implications of today's decline, especially in light of its recent acquisitions and dividend announcements.
Extendicare's Stock Drops 2.72% Today
With a market cap of CA$3.11 billion, Extendicare's decline today highlights the volatility that can affect even established companies in the healthcare sector.
Bull case
Despite today's dip, Extendicare has shown resilience in its earnings growth and strategic acquisitions. These factors could help the company bounce back in the future.
Bear case
The recent decline may indicate some underlying issues with Extendicare's operations or how the market views the company, which could impact its long-term growth.
Market Reaction
Advertisement
Extendicare Inc's stock decline today reflects a broader market reaction that might be influenced by recent financial results or overall investor sentiment. With a current price of CA$31.85, the stock's performance is under scrutiny, especially given its past fluctuations.
Investor Considerations
Investors should weigh the implications of today's 2.72% drop against Extendicare's recent strategic moves, including acquisitions aimed at enhancing its service offerings. Understanding the context of these changes is crucial for assessing the stock's potential recovery.
Future Outlook
While today's decline is concerning, Extendicare's long-term strategy focused on growth through acquisitions and improved service capabilities may provide a pathway for recovery. Investors should keep an eye on upcoming earnings reports and market reactions to gauge future performance.
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


